Castle Biosciences’ Tobin W. Juvenal sells 3,195 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Castle Biosciences (CSTL) Chief Commercial Officer Tobin W. Juvenal exercised options for 3,195 common shares at $29.50 per share on November 11, 2026, and sold 3,195 shares the same day at a weighted-average $35.07 per share. Sale prices ranged from $35.04 to $35.11. The options were fully vested, and no Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock option (right to buy) F2 | 3,195 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,195 | $29.50 | $94K |
| Sale | Common Stock F1 | 3,195 | $35.07 | $112K |
Footnotes (2)
- F1. This transaction was executed in multiple trades at prices ranging from $35.04 to $35.11, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. The shares subject to the option are fully vested.
Key Figures
Key Terms
weighted-average sale price financial
fully vested financial
stock option financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many CSTL options remained after Tobin W. Juvenal's exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.